Tourmaline Bio Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
48.67
|
|
Average Rating
|
4.63
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.82
|
-0.78
|
0.04
|
4.88%
|
|
2024-06-30
|
-0.71
|
-0.68
|
0.03
|
4.23%
|
|
2024-03-31
|
-0.67
|
-0.55
|
0.12
|
17.91%
|
|
2023-12-31
|
-0.79
|
-0.81
|
-0.02
|
-2.53%
|
|
2023-09-30
|
-0.60
|
-1.64
|
-1.04
|
-173.68%
|
|
2023-06-30
|
-0.20
|
-3.49
|
-3.29
|
-1647.35%
|
|
2023-03-31
|
-0.46
|
-0.37
|
0.09
|
18.68%
|
|
2022-12-31
|
-0.49
|
-5.20
|
-4.71
|
-961.22%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-2.01
|
|
2023-12-31
|
-6.32
|
|
2022-12-31
|
-18.70
|
|
2021-12-31
|
-23.80
|
|
2020-12-31
|
-0.16
|